<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Machado RD</submitter><funding>NIHR</funding><funding>British Heart Foundation</funding><funding>NIHR Cambridge Biomedical Research Centre</funding><funding>NHS Blood and Transplant</funding><funding>NHS</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Special Project Grant and Personal Chair Award to NWM</funding><funding>Wellcome Trust</funding><funding>Academy of Medical Sciences</funding><funding>NHS Trusts</funding><pagination>906-911</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9411922</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>59(9)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The molecular genetic basis of pulmonary arterial hypertension (PAH) is heterogeneous, with at least 26 genes displaying putative evidence for disease causality. Heterozygous variants in the &lt;i>ATP13A3&lt;/i> gene were recently identified as a new cause of adult-onset PAH. However, the contribution of &lt;i>ATP13A3&lt;/i> risk alleles to child-onset PAH remains largely unexplored.&lt;h4>Methods and results&lt;/h4>We report three families with a novel, autosomal recessive form of childhood-onset PAH due to biallelic &lt;i>ATP13A3&lt;/i> variants. Disease onset ranged from birth to 2.5 years and was characterised by high mortality. Using genome sequencing of parent-offspring trios, we identified a homozygous missense variant in one case, which was subsequently confirmed to cosegregate with dis</pubmed_abstract><journal>Journal of medical genetics</journal><pubmed_title>Biallelic variants of &lt;i>ATP13A3&lt;/i> cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortality.</pubmed_title><pmcid>PMC9411922</pmcid><funding_grant_id>204809/Z/16/Z</funding_grant_id><funding_grant_id>SBF005\1115</funding_grant_id><funding_grant_id>BRC-1215-20014</funding_grant_id><pubmed_authors>Debeljak M</pubmed_authors><pubmed_authors>Bleda M</pubmed_authors><pubmed_authors>Southgate L</pubmed_authors><pubmed_authors>Ekstein J</pubmed_authors><pubmed_authors>Hoover-Fong JE</pubmed_authors><pubmed_authors>Machado RD</pubmed_authors><pubmed_authors>Golden WC</pubmed_authors><pubmed_authors>Romer LH</pubmed_authors><pubmed_authors>NIHR Bioresource – Rare Diseases</pubmed_authors><pubmed_authors>Morrell NW</pubmed_authors><pubmed_authors>Hadinnapola C</pubmed_authors><pubmed_authors>Vesel S</pubmed_authors><pubmed_authors>Harris MA</pubmed_authors><pubmed_authors>Fineman JR</pubmed_authors><pubmed_authors>Hirsch Y</pubmed_authors><pubmed_authors>Welch CL</pubmed_authors><pubmed_authors>Coulson JD</pubmed_authors><pubmed_authors>Chung WK</pubmed_authors><pubmed_authors>Colglazier E</pubmed_authors><pubmed_authors>Griffin EL</pubmed_authors><pubmed_authors>Nogee L</pubmed_authors><pubmed_authors>Haimel M</pubmed_authors><pubmed_authors>Graf S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biallelic variants of &lt;i>ATP13A3&lt;/i> cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortality.</name><description>&lt;h4>Background&lt;/h4>The molecular genetic basis of pulmonary arterial hypertension (PAH) is heterogeneous, with at least 26 genes displaying putative evidence for disease causality. Heterozygous variants in the &lt;i>ATP13A3&lt;/i> gene were recently identified as a new cause of adult-onset PAH. However, the contribution of &lt;i>ATP13A3&lt;/i> risk alleles to child-onset PAH remains largely unexplored.&lt;h4>Methods and results&lt;/h4>We report three families with a novel, autosomal recessive form of childhood-onset PAH due to biallelic &lt;i>ATP13A3&lt;/i> variants. Disease onset ranged from birth to 2.5 years and was characterised by high mortality. Using genome sequencing of parent-offspring trios, we identified a homozygous missense variant in one case, which was subsequently confirmed to cosegregate with dis</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-05-29T16:11:37.81Z</modification><creation>2025-04-04T09:32:19.981Z</creation></dates><accession>S-EPMC9411922</accession><cross_references><pubmed>34493544</pubmed><doi>10.1136/jmedgenet-2021-107831</doi></cross_references></HashMap>